What are the dose equivalents for injectable corticosteroids such as hydrocortisone, prednisolone, methylprednisolone, dexamethasone, and betamethasone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Injectable Corticosteroid Dose Equivalents

For injectable corticosteroids, use the following dose equivalents: 20 mg prednisolone = 20 mg prednisone = 16 mg methylprednisolone = 80 mg hydrocortisone = 3 mg dexamethasone = 3 mg betamethasone. These relationships are explicitly defined in FDA labeling and provide the standard conversion framework for clinical practice 1, 2.

Standard Dose Equivalency Table

The FDA-approved conversion ratios for oral and intravenous administration are:

  • Hydrocortisone: 80 mg
  • Prednisolone: 20 mg
  • Prednisone: 20 mg
  • Methylprednisolone: 16 mg
  • Dexamethasone: 3 mg
  • Betamethasone: 3 mg
  • Triamcinolone: 16 mg

These equivalencies apply specifically to oral or intravenous routes 1, 2.

Critical Caveat for Injectable Routes

When corticosteroids are injected intramuscularly or into joint spaces, their relative properties may be greatly altered 1, 2. The standard equivalency table becomes unreliable for intra-articular, epidural, or other local injection routes due to:

  • Differential depot formation and residence time
  • Variable absorption kinetics from injection sites
  • Formulation-specific physicochemical properties (particulate vs. soluble preparations)
  • Microcrystal formation affecting local tissue exposure 3

Physiologic Dose Reference Points

For context in clinical decision-making, physiologic replacement doses are 4:

  • Hydrocortisone: 15-25 mg/day
  • Prednisolone/Prednisone: 4-6 mg/day
  • Methylprednisolone: 3-5 mg/day
  • Dexamethasone: 0.25-0.5 mg/day

Any dose exceeding these thresholds for >3-4 weeks poses risk for adrenal suppression 4.

Practical Application Algorithm

For systemic administration (IV/IM):

  1. Use the standard equivalency ratios above for dose conversion
  2. Recognize that hydrocortisone provides both glucocorticoid and mineralocorticoid activity, while synthetic agents (methylprednisolone, dexamethasone) lack significant mineralocorticoid effects 5
  3. Consider pharmacokinetic differences: dexamethasone has longer half-life (36-72 hours) versus hydrocortisone (8-12 hours)

For local injections (intra-articular, epidural):

  1. Do not rely on standard equivalency tables
  2. Use formulation-specific dosing: lowest effective doses include dexamethasone 4 mg, methylprednisolone 20 mg, triamcinolone 10 mg, betamethasone 3 mg for epidural injections 6
  3. Particulate preparations (triamcinolone, methylprednisolone acetate) provide longer duration but higher risk of local complications 3
  4. Soluble preparations (dexamethasone, betamethasone sodium phosphate) have shorter duration with reduced local tissue damage risk 3

Important Clinical Considerations

The equivalency ratios reflect genomic (classical) glucocorticoid effects but do not account for non-genomic effects, which follow a completely different potency hierarchy 7. For high-dose pulse therapy, this distinction becomes clinically relevant—methylprednisolone may be preferable to prednisolone for pulse therapy due to superior non-genomic potency 7.

Higher doses do not provide proportionally greater benefit but substantially increase adverse effects, particularly hyperglycemia and HPA axis suppression 6. Always use the lowest effective dose to minimize complications while achieving therapeutic goals.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.